| Ytd | 40.56% | |
| 1y | 184.02% |
| Open | 16.75 | Prev Close | 16.63 | Low | 16.37 | High | 16.80 | Mkt Cap | 424.74M |
| Vol | 0.00 | Avg Vol | 2.75M | EPS | 0.13 | P/E | 127.15 | Forward P/E | 38.71 |
| Beta | 1.74 | Short Ratio | 3.35 | Inst. Own | 108.31% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 07-28 | 50-d Avg | 13.41 | 200-d Avg | 11.02 | 1yr Est | 15.11 |
NEO News
NeOnc (Nasdaq: NTHI) will host an investor conference call and webcast on Wednesday, August 12, 2026
NeoGenomics (NEO) is at a 52-week high, but can investors hope for more gains in the future? We take
On July 31, 2026, NeoGenomics Inc (NEO) shares fell 3.7% to $15.29, reflecting a mixed price perform
NeoGenomics, Inc. (NASDAQ: NEO - Get Free Report) reached a new 52-week high on Wednesday after the
Gainers Autonomix Medical (NASDAQ:AMIX) shares increased by 89.4% to $5.21 during Wednesday's r
Gainers Autonomix Medical (NASDAQ:AMIX) shares moved upwards by 62.5% to $4.47 during Wednesday'
Needham analyst Mike Matson maintains NeoGenomics (NASDAQ:NEO) with a Buy and raises the price ta
NeoGenomics NASDAQ: NEO raised its full-year 2026 revenue and adjusted EBITDA guidance after reporti
NeoGenomics (NASDAQ:NEO) raises FY2026 sales outlook from $797.000 million-$803.000 million to $802.
NeoGenomics (NASDAQ:NEO) reported quarterly earnings of $0.05 per share which beat the analyst conse
FORT MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics announced its second-quarter results for the period e
American Capital Management Inc. lowered its position in shares of NeoGenomics, Inc. (NASDAQ: NEO) b
Benchmark analyst Bruce D. Jackson maintains NeoGenomics (NASDAQ:NEO) with a Buy and raises the p
FBT surged 51.6% in one year but carries higher risk and costs. VHT offers broader diversification a
FBT delivered 52.4% returns over one year but with deeper drawdowns, while XLV's diversified approac
NeoGenomics, Inc. (the "Company") (NASDAQ:NEO), a leading provider of oncology diagnostic so
FORT MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics Announces Settlement of Voluntary Disclosure to OIG-H
CALABASAS, Calif., July 15, 2026 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI
FORT MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics launched PTEN IHC CDx, the first IHC companion diagno
FORT MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics will report its second quarter 2026 financial results
FORT MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics announced the appointment of Carolyn Starrett to its
Authorization covers all three NEO100 programs across adult Phase 1 through Phase 2, plus pediatric
NeoGenomics (NEO) was a big mover last session on higher-than-average trading volume. The latest tre
Neo Performance Materials Inc. (NEO:CA) Shareholder/Analyst Call Prepared Remarks Transcript
FORT MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics Announces Pricing of Offering of $275 Million Convert
Employers Tighten Focus on AI and Human Skills as Global Tech Hiring Moderates PR Newswire MILWAUKEE
Companies Reporting Before The Bell • EHang Holdings (NASDAQ:EH) is expected to report quarterly lo
Shares of International Flavors & Fragrances Inc. (NYSE: IFF) fell during Wednesday’s session a
Shares of NeoGenomics, Inc. (NASDAQ: NEO) rose sharply in today’s pre-market trading after the comp
Companies Reporting Before The Bell • Barclays (NYSE:BCS) is likely to report quarterly earnings at
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earn
Companies Reporting Before The Bell • Warner Music Gr (NASDAQ:WMG) is likely to report quarterly ea